Search - tctmd.com

Displaying 681 - 700 of 1293

Sort: Relevancy | Date

News Daily News

Aprobado el Idarucizumab, Primer Antídoto de NOAC; El Deseo es no Demorar las Intervenciones

Todd Neale

October 26, 2015

News Daily News

Actualización de la Directriz Impulsa la PCI de la Arteria no Causante y Saca de la Pelea a la Trombectomía por Aspiración

Todd Neale

October 26, 2015

News Conference News TCT 2015

VISION: OCT-Guided Atherectomy Safe, Effective for PAD Intervention

October 14, 2015

News Daily News

Test de troponina I de alta sensibilidad podría eliminar el IM en gran número de pacientes

Todd Neale

October 13, 2015

Presentation TCT 2015

Two US PAD Trials That May Well Change Your Practice: Updates on the ENDOMAX and LIBERTY-360 Studies

Presenter: Hans Krankenberg, Lindsay S. Machan, Herbert D. Aronow

October 11, 2015

Presentation TCT 2015

Update on Bioresorbable Scaffolds for PAD

Presenter: Prakash Krishnan, Mahmood K. Razavi

October 11, 2015

Presentation TCT 2015

PAR-1 Antagonists and P2Y12 Inhibitors: What Are the Data and the Place of These Medications in the PAD Population (for Secondary Cardiovascular Prevention and PAD Itself)?

Presenter: Gary M. Ansel, Michael R. Jaff, Ori Ben-Yehuda

October 11, 2015

News Daily News

ADAPT-DES 亚组研究：实践变化可能会进一步降低已处于低水平的支架血栓发生率

Yael L. Maxwell

October 09, 2015

News Daily News

ADAPT-DES Substudy: Practice Changes May Decrease Already Low Stent Thrombosis Rates Even Further

Yael L. Maxwell

October 09, 2015

News Daily News

Subestudio ADAPT-DES: Los Cambios de la Práctica podrían disminuir aún más los ya bajos índices de trombosis del stent

Yael L. Maxwell

October 09, 2015

News Industry News

Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015

October 07, 2015

News Daily News

在PCI患者中切入部位和坎格雷洛之间没有相互作用

Caitlin E. Cox

October 06, 2015

News Industry News

SurModics Receives FDA IDE Approval for Early Feasibility Study of the SurVeil™ Drug-Coated Balloon

October 06, 2015

News Daily News

No Interplay Between Access Site, Cangrelor Effects in PCI Patients

Caitlin E. Cox

October 06, 2015

News Daily News

No hay interacción entre el punto de acceso y los efectos del Cangrelor en pacientes con PCI

Caitlin E. Cox

October 06, 2015

News Daily News

观察性研究揭示了血管内和手术方案在治疗症状性 PAD 时的差异

L.A. McKeown

October 05, 2015

News Daily News

Un Estudio observacional Arroja Luz sobre las Opciones Endovascular y Quirúrgica para la EAP Sintomática

L.A. McKeown

October 05, 2015

News Daily News

Observational Study Sheds Light on Endovascular vs Surgical Options for Symptomatic PAD

L.A. McKeown

October 05, 2015

Presentation

Lower Extremity Bypass Surgery and Peripheral Endovascular Interventions for Symptomatic PAD

Presenter: Thomas T. Tsai

October 02, 2015

News Daily News

在采用TAVR的早期，在试验中心以外接受治疗的患者的死亡率并非更高

October 01, 2015

Advertisement

Aprobado el Idarucizumab, Primer Antídoto de NOAC; El Deseo es no Demorar las Intervenciones

Actualización de la Directriz Impulsa la PCI de la Arteria no Causante y Saca de la Pelea a la Trombectomía por Aspiración

VISION: OCT-Guided Atherectomy Safe, Effective for PAD Intervention

Test de troponina I de alta sensibilidad podría eliminar el IM en gran número de pacientes

Two US PAD Trials That May Well Change Your Practice: Updates on the ENDOMAX and LIBERTY-360 Studies

Update on Bioresorbable Scaffolds for PAD

PAR-1 Antagonists and P2Y12 Inhibitors: What Are the Data and the Place of These Medications in the PAD Population (for Secondary Cardiovascular Prevention and PAD Itself)?

ADAPT-DES 亚组研究：实践变化可能会进一步降低已处于低水平的支架血栓发生率

ADAPT-DES Substudy: Practice Changes May Decrease Already Low Stent Thrombosis Rates Even Further

Subestudio ADAPT-DES: Los Cambios de la Práctica podrían disminuir aún más los ya bajos índices de trombosis del stent

Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015

在PCI患者中切入部位和坎格雷洛之间没有相互作用

SurModics Receives FDA IDE Approval for Early Feasibility Study of the SurVeil™ Drug-Coated Balloon

No Interplay Between Access Site, Cangrelor Effects in PCI Patients

No hay interacción entre el punto de acceso y los efectos del Cangrelor en pacientes con PCI

观察性研究揭示了血管内和手术方案在治疗症状性 PAD 时的差异

Un Estudio observacional Arroja Luz sobre las Opciones Endovascular y Quirúrgica para la EAP Sintomática

Observational Study Sheds Light on Endovascular vs Surgical Options for Symptomatic PAD

Lower Extremity Bypass Surgery and Peripheral Endovascular Interventions for Symptomatic PAD

在采用TAVR的早期，在试验中心以外接受治疗的患者的死亡率并非更高

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content